| Aspen Pharma Schweiz GmbH - Alluzience, Injektionslösung |
| 68145 | | 01 | | Alluzience | | Injektionslösung | | M03AX01 | | Botulinum Toxin | | 10.12.2021 | | |
|
| Composition |
| complexus toxini botulinici A et haemagglutinini 125 U., histidinum, saccharum, natrii chloridum corresp. natrium 2.156 mg, polysorbatum 80, acidum hydrochloricum q.s. ad pH pro vitro. |
| Packungsbestandteile |
| Injection solution | | | | | | | | | Inactive agents | Dose |
|---|
| Hydrochloric Acid | | | Complexus Toxini Botulinici A | | | Haemagglutinini | 125 U | | Histidine | | | Sodium Chloride | | | Polysorbatum 80 | | | Saccharum | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | A | | No | | 002 | 2 | | | A | | No |
|
